Drug Interaction Studies with Dexlansoprazole Modified Release (TAK-390MR), a Proton Pump Inhibitor with a Dual Delayed-Release Formulation: Results of Four Randomized, Double-Blind, Crossover, Placebo-Controlled, Single-Centre Studies

Author： Vakily Majid   Lee Ronald D.   Wu Jingtao   Gunawardhana Lhanoo   Mulford Darcy  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.29, Iss.1, 2009-01, pp. : 35-50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic-Pharmacodynamic Interaction between Nebicapone, a Novel Catechol-O-Methyltransferase Inhibitor, and Controlled-Release Levodopa/Carbidopa 200 mg/50 mg: Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects

By Vaz-da-Silva Manuel  

Drugs in R&D, Vol. 9, Iss. 6, 2008-01 ,pp. : 435-446

Adis International

Access to resources Recommend Favorite

Safety, Tolerability and Pharmacokinetics of Sugammadex Using Single High Doses (Up to 96 mg/kg) in Healthy Adult Subjects: A Randomized, Double-Blind, Crossover, Placebo-Controlled, Single-Centre Study

By Peeters Pierre A.M.  

Clinical Drug Investigation, Vol. 30, Iss. 12, 2010-12 ,pp. : 867-874

Adis International

Access to resources Recommend Favorite

Analgesic Efficacy of Quick-Release versus Standard Lornoxicam for Pain after Third Molar Surgery: A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Trial

By Møller Philip L.   Nørholt Sven E.  

Clinical Drug Investigation, Vol. 28, Iss. 12, 2008-01 ,pp. : 757-766

Adis International

Access to resources Recommend Favorite

Gabapentin Extended-Release Tablets for the Treatment of Patients with Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled, Multicentre Study

By Wallace Mark S.  

Clinical Drug Investigation, Vol. 30, Iss. 11, 2010-11 ,pp. : 765-776

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Two 6-Day Frovatriptan Dosing Regimens Used for the Short-Term Prevention of Menstrual Migraine: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Two-Period Crossover, Single-Centre Study in Healthy Female Volunteers

By Wade Andrew  

Clinical Drug Investigation, Vol. 29, Iss. 5, 2009-01 ,pp. : 325-337

Adis International

Access to resources Recommend Favorite